Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CENTRAL GARDEN & PET COCENT · Entity 4307 | Director | August 06, 2020 | August 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CENTRAL GARDEN & PET CO
Report date August 06, 2020 · Filed August 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,547 |
Ending reported balance
After 2020-08-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-08-06 · Exercise / conversion · Acquired 4,199 · Balance 4,904 Row 2 · 2020-08-06 · Tax withholding · Disposed 3,357 · Balance 1,547 F1: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.76 · Expires 2020-08-09 | Direct | 0 |
Reported balance
After 2020-08-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-08-06 · Exercise / conversion · Disposed 4,199 · Balance 0 F2: Options were granted on February 14, 2017, and all shares are vested and have been exercised. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise.
F2: Options were granted on February 14, 2017, and all shares are vested and have been exercised.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date November 03, 2009 · Filed November 04, 2009
Section 16 reporting ended · disclosed 2009-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 1
1 source rowRow 1 · 2009-11-03 · Disposition to issuer · Disposed 19,158 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. |
| Stock Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2009-11-03 · Disposition to issuer · Disposed 2,890.44 · Balance 0 F2: Each unit is the economic equivalent of one share of common stock. F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. |
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2009-11-03 · Disposition to issuer · Disposed 17,492.74 · Balance 0 F2: Each unit is the economic equivalent of one share of common stock. F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
F2: Each unit is the economic equivalent of one share of common stock.
F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2020 Filed Aug 10, 2020 20:14 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,199 | $0.00 Strike: $31.76 | $0.00 |
DisclosureSEC source: 0001209191-20-045932 · doc4.xml · derivative · entry 3 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,199 shares Expires 2020-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options were granted on February 14, 2017, and all shares are vested and have been exercised. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:14 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Tax withholdingClass A Common Stock | 3,357 | $39.73 | $133,373.61 |
DisclosureSEC source: 0001209191-20-045932 · doc4.xml · nonDerivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,547 F1 · kind: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:14 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionClass A Common Stock | 4,199 | $31.76 | $133,360.24 |
DisclosureSEC source: 0001209191-20-045932 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 12, 2020 21:11 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | SaleClass A Common Stock | 10,079 | $31.92 | $321,682.37 |
DisclosureSEC source: 0001209191-20-028567 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705 F1 · price: The range of prices for the shares of Class A Common Stock is from $31.39 to $32.19. The Reporting Person undertakes that the Reporting Person will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:18 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | GrantStock Option (Right to Buy) · Derivative | 7,043 | $0.00 Strike: $28.40 | $0.00 |
DisclosureSEC source: 0001209191-20-009176 · doc4.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,043 Underlying: Class A Common Stock · 7,043 shares Expires 2026-02-11 F2 · derivative.exercise_date: One-third of the total options granted will become exercisable at each of 6 months, 18 months and 30 months after February 11, 2020, the date of the grant. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:18 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | GrantClass A Common Stock | 705 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009176 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,784 F1 · shares: Restricted stock award granted under the Company's Nonemployee Director Equity Incentive Plan, as amended. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:58 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | PurchaseClass A Common Stock | 1,000 | $21.97 | $21,970.00 |
DisclosureSEC source: 0001209191-19-045139 · doc4.xml · nonDerivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,079 Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:58 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | PurchaseClass A Common Stock | 3,000 | $21.90 | $65,700.00 |
DisclosureSEC source: 0001209191-19-045139 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,079 Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:36 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | GrantStock Option (Right to Buy) · Derivative | 7,174 | $0.00 Strike: $27.88 | $0.00 |
DisclosureSEC source: 0001209191-19-010078 · doc4.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,174 Underlying: Class A Common Stock · 7,174 shares Expires 2025-02-12 F2 · shares: Stock options granted under the Company's Nonemployee Director Equity Incentive Plan, as amended. F3 · derivative.exercise_date: One-third of the total options granted will become exercisable at each of 6 months, 18 months and 30 months after February 12, 2019, the date of the grant. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:36 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | GrantClass A Common Stock | 718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-010078 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,079 F1 · shares: Restricted stock award granted under the Company's Nonemployee Director Equity Incentive Plan, as amended Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:11 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,849 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001209191-19-003250 · doc4.xml · derivative · entry 3 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,849 shares Expires 2019-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the total options granted became exercisable at each of 6 months, 18 months, and 30 months after February 9, 2016, the date of the grant. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:11 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Tax withholdingClass A Common Stock | 1,931 | $34.54 | $66,696.74 |
DisclosureSEC source: 0001209191-19-003250 · doc4.xml · nonDerivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,361 F1 · kind: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:11 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionClass A Common Stock | 4,849 | $13.75 | $66,673.75 |
DisclosureSEC source: 0001209191-19-003250 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 15, 2018 20:26 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | SaleClass A Common Stock | 2,000 | $36.62 | $73,240.00 |
DisclosureSEC source: 0001209191-18-030228 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,443 F1 · price: The range of prices for the shares of Class A Common Stock is from $36.50 to $36.75. Mr. Colligan undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:46 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | SaleClass A Common Stock | 3,000 | $37.25 | $111,750.00 |
DisclosureSEC source: 0001209191-18-011388 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,443 F1 · price: The range of prices for the shares of Class A Common Stock is from $37.13 to $37.35. Mr. Colligan undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:22 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,849 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001209191-18-010390 · doc4.xml · derivative · entry 8 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,849 Underlying: Class A Common Stock · 4,849 shares Expires 2019-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-third of the total options granted became exercisable at each of 6 months, 18 months, and 30 months after February 9, 2016, the date of the grant. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:22 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,099 | $0.00 Strike: $31.76 | $0.00 |
DisclosureSEC source: 0001209191-18-010390 · doc4.xml · derivative · entry 7 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,199 Underlying: Class A Common Stock · 2,099 shares Expires 2020-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-third of the total options granted became exercisable at each of 6 months, 18 months and 30 months after February 14, 2017, the date of the grant. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:22 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | GrantStock Option (Right to Buy) · Derivative | 5,415 | $0.00 Strike: $36.94 | $0.00 |
DisclosureSEC source: 0001209191-18-010390 · doc4.xml · derivative · entry 6 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Underlying: Class A Common Stock · 5,415 shares Expires 2021-08-13 F3 · shares: Stock options granted under the Company's Nonemployee Director Equity Incentive Plan, as amended. F4 · derivative.exercise_date: One-third of the total options granted will become exercisable at each of 6 months, 18 months and 30 months after February 13, 2018, the date of the grant. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:22 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Tax withholdingClass A Common Stock | 1,809 | $36.87 | $66,697.83 |
DisclosureSEC source: 0001209191-18-010390 · doc4.xml · nonDerivative · entry 5 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,443 F2 · kind: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:22 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionClass A Common Stock | 4,849 | $13.75 | $66,673.75 |
DisclosureSEC source: 0001209191-18-010390 · doc4.xml · nonDerivative · entry 4 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:22 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Tax withholdingClass A Common Stock | 1,809 | $36.87 | $66,697.83 |
DisclosureSEC source: 0001209191-18-010390 · doc4.xml · nonDerivative · entry 3 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,403 F2 · kind: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:22 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionClass A Common Stock | 2,099 | $31.76 | $66,664.24 |
DisclosureSEC source: 0001209191-18-010390 · doc4.xml · nonDerivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:22 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | GrantClass A Common Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010390 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,113 F1 · shares: Restricted stock award granted under the Company's Nonemployee Director Equity Incentive Plan, as amended Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 00:31 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | SaleClass A Common Stock | 3,500 | $32.97 | $115,391.15 |
DisclosureSEC source: 0001209191-17-049318 · doc4.xml · nonDerivative · entry 3 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 F2 · price: The range of prices for the shares of Class A Common Stock is from $32.92 to $33.05. Mr. Colligan undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| August 14, 2017 Filed Aug 17, 2017 00:31 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionStock Option (right to buy) · Derivative | 6,762 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0001209191-17-049318 · doc4.xml · derivative · entry 4 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,762 shares Expires 2018-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options were granted on February 10, 2015 and all shares are vested & exercisable. Read SEC document |
| August 14, 2017 Filed Aug 17, 2017 00:31 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Tax withholdingClass A Common Stock | 1,960 | $34.03 | $66,698.80 |
DisclosureSEC source: 0001209191-17-049318 · doc4.xml · nonDerivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,071 F1 · kind: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise. Read SEC document |
| August 14, 2017 Filed Aug 17, 2017 00:31 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionClass A Common Stock | 6,762 | $9.86 | $66,673.32 |
DisclosureSEC source: 0001209191-17-049318 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 00:33 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | GrantStock Option (Right to Buy) · Derivative | 6,298 | $0.00 Strike: $31.76 | $0.00 |
DisclosureSEC source: 0001209191-17-011287 · doc4.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,298 Underlying: Class A Common Stock · 6,298 shares Expires 2020-08-09 F2 · shares: Stock options granted under the Company's Nonemployee Director Equity Incentive Plan, as amended. F3 · derivative.exercise_date: One-third of the total options granted will become exercisable at each of 6 months, 18 months and 30 months after February 14, 2017, the date of the grant. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 00:33 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | GrantClass A Common Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-011287 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,269 F1 · shares: Restricted stock award granted under the Company's Nonemployee Director Equity Incentive Plan, as amended. Read SEC document |
| February 07, 2017 Filed Feb 7, 2017 23:37 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | SaleClass A Common Stock | 2,500 | $29.90 | $74,750.00 |
DisclosureSEC source: 0001209191-17-008443 · doc4.xml · nonDerivative · entry 3 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,639 Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 23:37 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,848 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001209191-17-008443 · doc4.xml · derivative · entry 4 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,698 Underlying: Class A Common Stock · 4,848 shares Expires 2019-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Stock options granted under the Company's Nonemployee Director Equity Incentive Plan, as amended. F3 · derivative.exercise_date: One-third of the total options granted will become exercisable at each of 6 months, 18 months and 30 months after February 9, 2016 the date of the grant. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 23:37 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Tax withholdingClass A Common Stock | 2,164 | $30.81 | $66,672.84 |
DisclosureSEC source: 0001209191-17-008443 · doc4.xml · nonDerivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,139 F1 · shares: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the average of the high and low sales prices on the date of exercise. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 23:37 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionClass A Common Stock | 4,848 | $13.75 | $66,660.00 |
DisclosureSEC source: 0001209191-17-008443 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2016 Filed Dec 13, 2016 23:47 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | SaleClass A Common Stock | 4,580 | $29.50 | $135,110.00 |
DisclosureSEC source: 0001209191-16-155022 · doc4.xml · nonDerivative · entry 3 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,455 Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 23:47 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionStock Option (right to buy) · Derivative | 6,761 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0001209191-16-155022 · doc4.xml · derivative · entry 4 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,762 Underlying: Class A Common Stock · 6,761 shares Expires 2018-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the total options granted became exercisable at each of 6 months, 18 months and 30 months after February 10, 2015, the date of the grant. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 23:47 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Tax withholdingClass A Common Stock | 2,181 | $30.57 | $66,673.17 |
DisclosureSEC source: 0001209191-16-155022 · doc4.xml · nonDerivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,035 F1 · kind: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the average of the high and low sales prices on the date of exercise. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 23:47 UTC | CENTRAL GARDEN & PET CO CENT · Entity 4307 | Exercise / conversionClass A Common Stock | 6,761 | $9.86 | $66,663.46 |
DisclosureSEC source: 0001209191-16-155022 · doc4.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 23:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerStock Units · Derivative | 17,492.74 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051086 · c91871_4x0.xml · derivative · entry 3 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 17,492.74 shares Expires not disclosed F2 · derivative.exercise_price: Each unit is the economic equivalent of one share of common stock. F3 · price: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. F3 · derivative.exercise_date: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. F3 · derivative.expiration_date: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 23:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerStock Equivalent Units · Derivative | 2,890.44 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051086 · c91871_4x0.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,890.44 shares Expires not disclosed F2 · derivative.exercise_price: Each unit is the economic equivalent of one share of common stock. F3 · price: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. F3 · derivative.exercise_date: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. F3 · derivative.expiration_date: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 23:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerCommon Shares | 19,158 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051086 · c91871_4x0.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| June 01, 2009 Filed Jun 2, 2009 16:25 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 1,032.79 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-09-000072 · col735.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,452.48 Underlying: Common Shares · 1,032.79 shares Expires not disclosed F3 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan. F4 · derivative.exercise_price: Not Applicable. F7 · price: Not Applicable. F5 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan. F6 · derivative.expiration_date: Not Applicable. F8 · balance_after: Includes shares acquired through May 26, 2009 pursuant to a dividend reinvestment feature of the Directors Compensation Plan. Read SEC document |
| June 01, 2009 Filed Jun 2, 2009 16:25 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-09-000072 · col735.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,158 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| December 01, 2008 Filed Dec 1, 2008 22:43 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 1,674.6 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000095 · col685.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,313.7 Underlying: Common Shares · 1,674.6 shares Expires not disclosed F3 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan. F4 · derivative.exercise_price: Not Applicable. F7 · price: Not applicable. F5 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan. F6 · derivative.expiration_date: Not Applicable. F8 · balance_after: Includes shares acquired through November 25, 2008 pursuant to a dividend reinvestment feature of the Directors Compensation Plan. Read SEC document |
| December 01, 2008 Filed Dec 1, 2008 22:43 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 2,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000095 · col685.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,591 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| November 21, 2008 Filed Nov 24, 2008 20:19 UTC | Merck & Co., Inc. SGP · Entity 2807 | PurchaseCommon Shares | 5,000 | $13.88 | $69,400.00 |
DisclosureSEC source: 0000310158-08-000076 · col698.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,024 Read SEC document |
| November 21, 2008 Filed Nov 25, 2008 19:48 UTC Amendment | Merck & Co., Inc. SGP · Entity 2807 | PurchaseCommon Shares | 5,000 | $13.88 | $69,400.00 |
DisclosureSEC source: 0000310158-08-000078 · col701.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,024 Read SEC document |
| May 30, 2008 Filed May 30, 2008 21:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 1,121.47 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000050 · col672.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,527.14 Underlying: Common Shares · 1,121.47 shares Expires not disclosed F3 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan. F4 · derivative.exercise_price: Not Applicable. F7 · price: Not Applicable. F5 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan. F6 · derivative.expiration_date: Not Applicable. F8 · balance_after: Includes shares acquired through May 27, 2008 pursuant to a dividend reinvestment feature of the Directors Compensation Plan. Read SEC document |
| May 30, 2008 Filed May 30, 2008 21:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000050 · col672.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,024 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| December 01, 2007 Filed Dec 4, 2007 21:48 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 1,421.73 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-07-000082 · col633.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,321.08 Underlying: Common Shares · 1,421.73 shares Expires not disclosed F3 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan. F4 · derivative.exercise_price: Not Applicable. F7 · price: Not Applicable. F5 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan. F6 · derivative.expiration_date: Not Applicable. F8 · balance_after: Includes shares acquired through November 27, 2007 pursuant to a dividend reinvestment feature of the Directors Compensation Plan. Read SEC document |
| December 01, 2007 Filed Dec 4, 2007 21:48 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-07-000082 · col633.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,344 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.